Milliman Maps Options for Plans to Keep Drug Costs Low for Dual Eligibles After VBID, FAI Sunset
Milliman examines how the discontinuation of the Medicare Advantage VBID demonstration and the Medicare-Medicaid Financial Alignment Initiative removes key tools that states and plans used to reduce Part D cost-sharing to $0 for low-income dual-eligible beneficiaries. The paper outlines four remaining strategies—alternative Part D benefit designs, Medicaid value-added services, state pharmacy assistance programs, and state-only funds—that Medicaid agencies and Dual-Eligible Special Needs Plans can use to preserve affordable drug access. This matters for Medicaid managed care because millions of dual eligibles enrolled in D-SNPs relied on these now-sunsetting programs, requiring states and plans to redesign benefit and funding approaches.
This is outside commentary from Milliman, not part of Medicaid Monitor's independently scored news coverage.